The female factor: Predicting compliance with a post-prostatectomy erectile preservation program

Journal of Sexual Medicine

Volumn 7, Issue 11, 2010, Pages 3659-3665

  Moskovic, Daniel J ^a,b   Mohamed, Osama ^a   Sathyamoorthy, Kumaran ^a   Miles, Brian J ^a   Link, Richard E ^a   Lipshultz, Larry I ^a   Khera, Mohit ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b The Sanford C Bernstein Co Center for Leadership and Ethics   (United States)

Author keywords

Compliance; Erectile Dysfunction; Erectile Preservation; Female Sexual Function; Prostatectomy

Indexed keywords

AGENTS ACTING ON THE GENITAL SYSTEM; PAPAVERINE PLUS PHENTOLAMINE PLUS PROSTAGLANDIN E1; PROSTAGLANDIN E1; SILDENAFIL; TRIMIX; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; ERECTILE DYSFUNCTION; EVENING DOSAGE; FOLLOW UP; HUMAN; MALE; MEDICAL APPARATUS, EQUIPMENT AND SUPPLIES; PATIENT COMPLIANCE; PENIS ERECTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATECTOMY; SEXUALITY; SUPPOSITORY; VACUUM ERECTION DEVICE;

EID: 78049455046     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.02014.x     Document Type: Article

References (28)

1. Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3, 478 consecutive patients: Long-term results. J Urol 2004;172:910-4.
2. Briganti A, Capitanio U, Chun FK, Karakiewicz PI, Salonia A, Bianchi M, Cestari A, Guazzoni G, Rigatti P, Montorsi F. Prediction of sexual function after radical prostatectomy. Cancer 2009;115:3150-9.
3. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. J Urol 1997;158:1408-10.
4. Mulhall JP, Graydon RJ. The hemodynamics of erectile dysfunction following nerve-sparing radical retropubic prostatectomy. Int J Impot Res 1996;8:91-4.
5. De Luca V, Pescatori ES, Taher B, Zambolin T, Giambroni L, Frego E, Cosciani Cunico S. Damage to the erectile function following radical pelvic surgery: Prevalence of veno-occlusive dysfunction. Eur Urol 1996;29:36-40.
6. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: A meta-analysis. J Sex Med 2009;6:2538-46.
7. Gontero P, Fontana F, Zitella A, Montorsi F, Frea B. A prospective evaluation of efficacy and compliance with a multistep treatment approach for erectile dysfunction in patients after non-nerve sparing radical prostatectomy. BJU Int 2005;95:359-65.
8. Salonia A, Gallina A, Zanni G, Briganti A, Deho F, Sacca A, Suardi N, Barbieri L, Guazzoni G, Rigatti P, Montorsi F. Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;53:564-70.
9. Jiann BP, Yu CC, Su CC, Tsai JY. Compliance of sildenafil treatment for erectile dysfunction and factors affecting it. Int J Impot Res 2006;18:146-9.
10. Mulhall J, Land S, Parker M, Waters WB, Flanigan RC. The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2005;2:532-40. discussion 40-2.
11. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, Giuliano F, Brock G. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008;20:479-86.
12. Ljunggren C, Hedelin H, Salomonsson K, Stroberg P. Giving patients with erectile dysfunction the opportunity to try all three available phosphodiesterase type 5 inhibitors contributes to better long-term treatment compliance. J Sex Med 2008;5:469-75.
13. Shindel A, Quayle S, Yan Y, Husain A, Naughton C. Sexual dysfunction in female partners of men who have undergone radical prostatectomy correlates with sexual dysfunction of the male partner. J Sex Med 2005;2:833-41. discussion 41.
14. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
15. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol 2004;22:2141-9.
16. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, Center MM, Ward E, Wu XC, Eheman C, Anderson R, Ajani UA, Kohler B, Edwards BK. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 2008;100:1672-94.
17. Han M, Partin AW, Pound CR, Epstein JI, Walsh PC. Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urol Clin North Am 2001;28:555-65.
18. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54:924-31.
19. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008;5:476-84.
20. Mulhall JP. The role and structure of a postradical prostatectomy penile rehabilitation program. Curr Urol Rep 2009;10:219-25.
21. Conaglen JV, Conaglen HM. The effects of treating male hypogonadism on couples' sexual desire and function. J Sex Med 2009;6:456-63.
22. Fisher WA, Rosen RC, Mollen M, Brock G, Karlin G, Pommerville P, Goldstein I, Bangerter K, Bandel TJ, Derogatis LR, Sand M. Improving the sexual quality of life of couples affected by erectile dysfunction: A double-blind, randomized, placebo-controlled trial of vardenafil. J Sex Med 2005;2:699-708.
23. Descazeaud A, Debre B, Flam TA. Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 2006;176:2594-8. discussion 98.
24. Clayton AH, Hamilton DV. Female sexual dysfunction. Psychiatr Clin North Am 2010;33:323-38.
25. Walsh KE, Berman JR. Sexual dysfunction in the older woman: An overview of the current understanding and management. Drugs Aging 2004;21:655-75.
26. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 2005;17:307-19.
27. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
28. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.